MYOCARDIAL TOXIC EFFECTS DURING RECOMBINANT INTERLEUKIN-2 THERAPY

被引：81

作者：

NORA, R

ABRAMS, JS

TAIT, NS

HIPONIA, DJ

SILVERMAN, HJ

机构：

[1] UNIV MARYLAND,SCH MED & MED SYST,CTR CANC,DEPT MED,DIV MED ONCOL,BALTIMORE,MD 21201

[2] UNIV MARYLAND,SCH MED & MED SYST,CTR CANC,DEPT MED,DIV PULM MED,BALTIMORE,MD 21201

来源：

关键词：

D O I：

10.1093/jnci/81.1.59

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：59 / 63

页数：5

共 20 条

[1] EFFECTS OF INTERLEUKIN-2 ON RENAL-FUNCTION IN PATIENTS RECEIVING IMMUNOTHERAPY FOR ADVANCED CANCER
BELLDEGRUN, A
WEBB, DE
AUSTIN, HA
STEINBERG, SM
WHITE, DE
LINEHAN, WM
ROSENBERG, SA
[J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) : 817 - 822
[2] DUTCHER JP, 1987, P AN M AM SOC CLIN, V6, P246
[3] ETTINGHAUSEN SE, 1987, BLOOD, V69, P1654
[4] FISHER RI, 1987, P AN M AM SOC CLIN, V6, P244
[5] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .2. PRECURSOR PHENOTYPE IS SEROLOGICALLY DISTINCT FROM PERIPHERAL LYMPHOCYTES-T, MEMORY CYTO-TOXIC THYMUS-DERIVED LYMPHOCYTES, AND NATURAL-KILLER CELLS
GRIMM, EA
RAMSEY, KM
MAZUMDER, A
WILSON, DJ
DJEU, JY
ROSENBERG, SA
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (03) : 884 - 897
[6] JESMOK G, 1988, P AM ASSOC CANC RES, V29, P435
[7] LOTZE MT, 1986, CANCER, V58, P2764, DOI 10.1002/1097-0142(19861215)58:12<2764::AID-CNCR2820581235>3.0.CO
[8] 2-Z
[9] MARGOLIN K, 1987, P AN M AM SOC CLIN, V6, P251
[10] NORA R, 1987, NEW ENGL J MED, V316, P275